Allison Bratzel
Stock Analyst at Piper Sandler
(4.85)
# 411
Out of 5,134 analysts
282
Total ratings
51.2%
Success rate
27.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Allison Bratzel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ENGN enGene Therapeutics | Upgraded: Buy | $4 | $2.41 | +65.98% | 6 | Nov 12, 2026 | |
| SRRK Scholar Rock Holding | Reiterated: Buy | $75 | $43.21 | +73.59% | 17 | Nov 11, 2026 | |
| IONS Ionis Pharmaceuticals | Reiterated: Buy | $87 | $29.06 | +199.38% | 16 | Nov 9, 2026 | |
| RARE Ultragenyx Pharmaceutical | Reiterated: Buy | $36 | $16.08 | +123.88% | 9 | Nov 5, 2026 | |
| ABVX ABIVAX Société Anonyme | Reiterated: Buy | $175 | $87.58 | +99.82% | 14 | Oct 21, 2026 | |
| AKBA Akebia Therapeutics | Reiterated: Buy | $4 | $0.4742 | +743.53% | 19 | Oct 21, 2026 | |
| ARDX Ardelyx | Reiterated: Buy | $15 | $3.09 | +385.44% | 10 | Oct 21, 2026 | |
| ARGX argenx SE | Reiterated: Buy | $1,215 | $960.04 | +26.56% | 35 | Oct 21, 2026 | |
| BMRN BioMarin Pharmaceutical | Reiterated: Buy | $90 | $57.23 | +57.26% | 10 | Oct 21, 2026 | |
| CDXS Codexis | Reiterated: Buy | $8 | $1.16 | +589.66% | 13 | Oct 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $130 | $120.97 | +7.46% | 14 | Oct 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $49 | $44.46 | +10.21% | 11 | Oct 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $68 | $50.65 | +34.25% | 22 | Oct 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $56 | $20.03 | +179.65% | 6 | Sep 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.04 | +284.62% | 7 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $13.82 | +117.08% | 7 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52 → $55 | $28.56 | +92.58% | 9 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $0.5584 | +79.08% | 10 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $3.71 | +223.45% | 6 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $9.18 | +226.80% | 7 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $11.49 | +4.44% | 7 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $21.89 | -36.04% | 10 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3 → $0.5 | $0.000001 | +49,999,900.00% | 5 | Jan 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $39.53 | n/a | 6 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $8 → $20 | $6.84 | n/a | 6 | Mar 14, 2024 |
enGene Therapeutics
Nov 12, 2026
Upgraded: Buy
Price Target: $4
Current: $2.41
Upside: +65.98%
Scholar Rock Holding
Nov 11, 2026
Reiterated: Buy
Price Target: $75
Current: $43.21
Upside: +73.59%
Ionis Pharmaceuticals
Nov 9, 2026
Reiterated: Buy
Price Target: $87
Current: $29.06
Upside: +199.38%
Ultragenyx Pharmaceutical
Nov 5, 2026
Reiterated: Buy
Price Target: $36
Current: $16.08
Upside: +123.88%
ABIVAX Société Anonyme
Oct 21, 2026
Reiterated: Buy
Price Target: $175
Current: $87.58
Upside: +99.82%
Akebia Therapeutics
Oct 21, 2026
Reiterated: Buy
Price Target: $4
Current: $0.4742
Upside: +743.53%
Ardelyx
Oct 21, 2026
Reiterated: Buy
Price Target: $15
Current: $3.09
Upside: +385.44%
argenx SE
Oct 21, 2026
Reiterated: Buy
Price Target: $1,215
Current: $960.04
Upside: +26.56%
BioMarin Pharmaceutical
Oct 21, 2026
Reiterated: Buy
Price Target: $90
Current: $57.23
Upside: +57.26%
Codexis
Oct 21, 2026
Reiterated: Buy
Price Target: $8
Current: $1.16
Upside: +589.66%
Oct 21, 2026
Reiterated: Buy
Price Target: $130
Current: $120.97
Upside: +7.46%
Oct 21, 2026
Reiterated: Hold
Price Target: $49
Current: $44.46
Upside: +10.21%
Oct 21, 2026
Reiterated: Buy
Price Target: $68
Current: $50.65
Upside: +34.25%
Sep 8, 2026
Reiterated: Buy
Price Target: $56
Current: $20.03
Upside: +179.65%
Aug 17, 2026
Reiterated: Buy
Price Target: $4
Current: $1.04
Upside: +284.62%
Aug 17, 2026
Reiterated: Buy
Price Target: $30
Current: $13.82
Upside: +117.08%
Aug 17, 2026
Reiterated: Buy
Price Target: $52 → $55
Current: $28.56
Upside: +92.58%
Aug 17, 2026
Reiterated: Hold
Price Target: $1
Current: $0.5584
Upside: +79.08%
Aug 17, 2026
Reiterated: Buy
Price Target: $12
Current: $3.71
Upside: +223.45%
Aug 17, 2026
Reiterated: Buy
Price Target: $30
Current: $9.18
Upside: +226.80%
Aug 7, 2026
Reiterated: Buy
Price Target: $12
Current: $11.49
Upside: +4.44%
Aug 7, 2026
Reiterated: Buy
Price Target: $14
Current: $21.89
Upside: -36.04%
Jan 23, 2026
Downgraded: Hold
Price Target: $3 → $0.5
Current: $0.000001
Upside: +49,999,900.00%
Jul 18, 2024
Reiterated: Buy
Price Target: $22
Current: $39.53
Upside: n/a
Mar 14, 2024
Upgraded: Buy
Price Target: $8 → $20
Current: $6.84
Upside: n/a